HHMI
LIN icon

Howard Hughes Medical Institute’s Linde LIN Stock Holding History

Howard Hughes Medical Institute’s Portfolio LIN Stock Details LIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-101
Closed -$43.1K – 293
2025
Q4 		$43.1K Hold
101
– – 0.02% 50
2025
Q3 		$48K Sell
101
-1
-1% -$473 0.03% 40
2025
Q2 		$47.9K Buy
+102
New +$46.6K 0.02% 38

Other funds holding LIN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Howard Hughes Medical Institute's LIN Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Linde (LIN) in Q1 2026, closing a stake of 101 shares — an estimated $43.1K sold.

Howard Hughes Medical Institute first reported a position in LIN in Q2 2025 and held it in 3 quarters. The position peaked at $48K in Q3 2025. 2,269 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Linde position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 101 Linde shares in Q1 2026, an estimated $43.1K.
  • Howard Hughes Medical Institute first reported a position in Linde in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Linde position peaked at $48K in Q3 2025.
  • 2,269 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.